The same CT. A different pair of eyes.
Pancreatic lesions hide in plain sight on routine abdominal CT. PANCREASaver® reviews the exact same images and marks what the human eye can overlook — automatically, in minutes, before the report is even started.
Real clinical CT images with actual PANCREASaver® output overlay. Radiologists always review and confirm AI findings.
An AI second reader that never blinks
PANCREASaver® is FDA Breakthrough-designated medical device software (SaMD). The moment an abdominal CT scan finishes, it reads the images, marks suspicious pancreatic lesions, and sends the alert back into the radiology workflow — so early pancreatic cancer is no longer missed.
Fully automated, real-time reading
Analysis starts automatically when the scan completes — no extra steps for physicians. CNN deep learning and radiomics engines run in parallel.
Small tumors, still detected
92.1% sensitivity for lesions under 2cm — closing the gap where eyes and conventional tools miss.
Clinically validated
5 international journal papers and a nationwide multicenter AUC of 0.95, led by the National Taiwan University Hospital team.
From scan to alert, in minutes
CT scan
Patient undergoes a routine abdominal CT; images stream into the PACS as usual.
AI reads in real time
PANCREASaver® analyzes the full pancreas within minutes — no clicks required.
Auto-mark + alert
The lesion is locked and marked; a priority alert fires back into the PACS worklist.
Radiologist review
The radiologist confirms the marks and signs the final report — AI never replaces the read.
One integration. Every workflow.
PANCREASaver® was designed around the way radiology departments already work. It connects to your existing PACS — no new viewer, no extra clicks, no rip-and-replace.
DICOM-native integration connects to the PACS/RIS infrastructure you already run — the AI fits the system, not the other way around.
Compatible with GE, Siemens, Philips, Canon and more — it runs on the scanners and viewers you already own.
Radiologists read exactly as they always have. AI works silently in the background and surfaces what matters.
Typically live in as little as 4 weeks with minimal IT lift — onboarding, training and go-live support included.
How the integration works
Connect
A DICOM link connects PANCREASaver® to your CT scanners and PACS.
Analyze
The AI triggers automatically the moment a scan completes — nothing to launch, nothing to click.
Alert
Suspicious studies are prioritized in the worklist with the lesion marked for the radiologist.
Report
Structured findings are delivered back into your reporting workflow, ready for review and sign-off.
Not a mockup — a system running in hospitals today
From Stone Web Viewer integration to Bridge login, PANCREASaver® is deployed at medical centers, regional hospitals and screening centers — 2,000+ scans reviewed.
PANCREASaver®
Published. Peer-reviewed. Verified.
Five papers in leading journals — every figure on this page carries a source you can open.
The Lancet Digital Health 2020
Nationwide validation (n=1,473) of the AI detection engine — the foundation of the 92.1% sub-2cm sensitivity and 92.8% specificity figures.
Radiology 2023
Nationwide multi-center performance with national-level AUC 0.95 — real clinical validation led by the NTUH team.
Real-world deployment
2,000+ cases interpreted in routine practice, including independent third-party validation — evidence from the field, not just the lab.
Explore PANCREASaver® further
For Clinicians
The full evidence hall — AUC curves, regulatory approvals, and the integration workflow.
Go to Clinicians →Clinical Evidence
5 international journal papers with topics, abstracts and PubMed links.
Open the evidence →Regulatory Status
TFDA license, FDA Breakthrough, 510(k) status, and 10 US/TW patents — stated exactly as they are.
See regulatory status →Common questions, direct answers
Yes. PANCREASaver® is DICOM-native and integrates with the PACS/RIS infrastructure you already run — no new viewer and no replacement of existing systems.
Typically live in as little as 4 weeks, with minimal IT lift. On-premises and cloud deployment options are available, and our team handles onboarding, training and go-live support.
No. Radiologists read exactly as they always have — AI runs automatically in the background and surfaces prioritized findings in the worklist.
It holds FDA Breakthrough Device Designation; a 510(k) was submitted in July 2026 and is under review. It is TFDA-licensed in Taiwan (license no. 衛部醫器製字第007946號).
Contrast-enhanced abdominal CT, per the approved indications — the same scans your department already performs, with no extra acquisition protocol.
Want to see it in action?
Book a live demo and let the AI show you what it sees on a real CT.
Talk to us